



MODELS OF EPILEPSY USED IN ANTIEPILEPTIC DRUG DISCOVERY: A REVIEW 
Review Article 
 
PHULEN SARMA, ANUSUYA BHATTACHARYYA 
MBBS, MD Pharmacology, Ph. D Scholar, AIIMS, New Delhi, India. 
Email: phulen10@gmail.com   
Received: 11 Sep 2014 Revised and Accepted: 10 Oct 2014 
ABSTRACT 
This article describes various experimental models of seizure and epilepsy. Epilepsy is characterised by recurrent unprovoked seizures. 
Antiepileptic drug discovery in animal models starts with the assumption that the experimental seizure model mimics human seizure. Hence a drug 
which suppresses ictogenesis or inhibits epileptogenesis in animal model is a potential antiepileptic drug for human and it needs further 
investigation. Phenytoin and Carbamazepine were identified with the help of relatively simple models like Maximal electroshock seizure and the 
pentylenetetrazole test. Lots of drugs were discovered with the help of these models but a big portion of patients still remains resistant to the 
available antiepileptic drugs. Again these simple seizure models are increasingly being questioned, are they providing us same type of drugs with 
same kind of mechanism of action? This question brings the importance of newer animal models that target epileptogenesis, pharmacoresistant 
epilepsy and models which mimic human epilepsy more closely. There is increased concern on agents for epilepsy disease modification and 
prevention. To solve these unmet needs, the research scientist must have a thorough knowledge of available animal models of epilepsy so that he 
can pick up the best model for his research. In this article, we are reviewing the diversity of animal models of epilepsy and their implications in 
antiepileptic drug discovery.  
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INTRODUCTION 
Epilepsy is a disease of the brain characterised by at least two 
unprovoked (or reflex) seizures occurring more than 24 hours apart 
[1].In epilepsy, there is a predisposition to generate epileptic seizures 
[2]. Seizure occurs due to abnormal excessive or synchronous 
neuronal activity in the brain and is associated with 
Epileptogenesis is a slow process. After several months of initial insult, 
spontaneous recurrent seizures begin to appear [3]. Epilepsy is 
considered to be resolved for individuals who are seizure-free for the 
last 10 years, with no seizure medicines for the last 5 years [1]. 
alterations in 
electrographic pattern, consciousness, sensation and behaviour [2, 3]. 
Secondary epilepsy may result from various insults like anoxia, 
trauma, tumours, metabolic abnormalities, neurotoxicity, drug 
withdrawal and encephalitis [3].  
Although lots of antiepileptic drugs are available in the market, almost 
33% patients continue to present seizure [4].There comes the 
importance of animal models, especially newer models which can 
model epilepsy in a more realistic way. However, there is a growing 
concern that conventional tests (MES and Sc. PTZ) identify only those 
drugs which have similar characteristics with existing drugs and these 
methods may fail to identify agents acting by novel mechanisms [5].  
To understand epilepsy better, we need to understand animal models 
better and vice-versa. Lots of new animal models are coming up. 
Models are even designed for epileptogenesis and pharmacoresistant 
epilepsy. Lots of research activity is required in these areas to bring out 
novel drugs which can treat, cure and prevent epilepsy better [4-7]. 
Although there are lots of review articles on disease models of 
epilepsy, maximum are reviews on only few models and the topic 
seems to be partially covered. After extensive search, also we could not 
get a single article which encompasses every aspect of disease models 
of epilepsy, from simple animal models to of genetic models, models of 
epileptogenesis, pharmacoresistant epilepsy, computational models 
and alternative to animal models. Hence this work was undertaken.  
Models of generalised seizures 
There are lots of models for generalised seizures. Few are discussed 
here.  
Maximal electroshock seizure 
This is a model of acute seizure and one of the gold standards in 
early stage of antiepileptic drug screening and probably the best 
validated preclinical test to predict effectiveness of drugs against 
Grand mal seizure [4,5]. The pattern of electrographic and 
behavioural patterns of these seizures is similar to human seizure 
[8]. This model identifies those compounds which prevent seizure 
spread [9]. 
Seizure can be induced with the help of either trans-corneal or 
trans-auricular electrodes. But there are lots of differences between 
seizures induced by these two methods as they tend to activate 
different parts of brain. Corneal electrodes preferentially activate 
forebrain structures.  
Tran-auricular electrodes activate brain stem and hence more effective 
in eliciting tonic convulsions. Seizure occurring during trans-auricular 
electrode stimulation occurs lower seizure threshold and is difficult to 
inhibit with anticonvulsant drugs than seizures induced by corneal 
electrodes. Again drugs preventing seizure spread are more effective in 
MES induced by corneal electrodes [4]. 
In the MES test, an electrical stimulus of 0.2 s in duration (50 mA in mice 
and 150 mA in rat at 60Hz) is delivered via corneal electrodes primed 
with an electrolyte solution containing an anaesthetic agent [9]. 
Local anaesthetic ensures adequate anaesthesia, contact and 
decreases an incidence of fatalities in mice [4]. 
After application of stimulus, tonic seizure occurs with extension of 
fore and hind limbs and body becomes stiff. At the end of tonic phase 
clonic seizures start, after 20-30 seconds generally the animal can 
come back to original position [4]. An agent which decrease the 
duration [10, 11] or abolish hind limb tonic extensor component of 
MES indicates it has ability to inhibit seizure spread [8,9]. 
In supramaximal current, MES test restricts itself to Na+channel 
blockers. But another variant of this test, the threshold MES test, it is 
possible to detect the effect of the drugs even on seizure threshold. 
With determination of individual seizure thresholds, it extends 
susceptible other categories antiepileptic drug e. g. GABA enhancing 
drugs, glutamate receptor antagonists etc. [4]. 
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Subcutaneous pentylene tetrazole (PTZ) method 
This model identifies compounds that raise seizure threshold [9]. 
Drugs effective against this seizure model are potential therapies for 
non-convulsive seizures (absence seizure) [9,12]. The subcutaneous 
convulsive dose of PTZ (produces clonic seizure in 97% animals lasting 
for at least 5 second duration i. e. CD97) for mouse is 85 mg/kg and in rat 
70 mg/kg. Animals are observed for 30 minutes [9]. 
The animal shows altered behavioural responses like vibrissae 
twitching, myoclonic jerk may be with associated vocalisation and 
straub’s tail, loss of righting reflex but regaining the same after few 
seconds, freezing movements, breathing is increased, jumping and 
proceed to clonic seizure and lastly hind limb tonic extensor phase 
[12]. Absence of clonic phase in the observed period indicates that 
the compound under investigation increases seizure threshold [9]. 
MES and Sc. PTZ model are use in the primary screen while 
evaluating antiepileptic drugs as per NIH anticonvulsant drug 
development programme. 
Timed PTZ infusion test 
PTZ dissolved in heparinised saline 0.9% to prepare 10 mg/ml 
concentration. PTZ is infused at a rate of 0.5 ml per minute. 
Parameters observed are latency to first clonus lasting longer than 5 
sec and appearance of tonic extensor phase of forelimb and/ or hind 
limb (TE). Infusion is stopped once TE is seen. Threshold doses for 




This test is claimed to show more consistent result as variability of 
absorption don’t come into account. Again another important 
advantage of this model is that with the help of it, we can measure 
seizure threshold. Sequence of response seen in this test are 
vibrissae twitching, myoclonic jerk with vocalisation, clonus and 
forelimb/hind limb tonic extensor [12]. 
Homocysteine 
When rats or mice are given homocystein thiolactone 1 g/kg i. p. 
they develop Generalised tonic clonic seizure with a latency period 
of almost one hour [13]. 
Models of generalised seizure (absence seizure) 
Although lots of animal models are available for absence seizure 
including genetic models, only few are discussed below. 
WAG/Rij model 
It is a strain of inbreed rats which show spontaneous spike and wave 
pattern in EEG with associated behavioural abnormalities as seen 
during human absence seizure. Drugs active against absence seizure 
are supposed to decrease these electrographic and behavioural 
abnormalities [14-16]. 
Gama hydroxybutyrate model (GHB) 
Administration of GHB causes changes of EEG and behavioural 
patterns which mimic human absence seizure. Rats when injected 
with GHB 100-150 mg/kg the shows periodic bursts of 4-6 Hz spike 
wave activity [13]. 
GAERS genetic absence epilepsy rat from strasbourg (GAERS) 
These animals show recurrent generalized non-convulsive seizures 
with behavioural arrest, staring and vibrissae twitching, which is 
accompanied by bilateral and synchronous spike-and-wave discharges 
(SWD).  
ntiabsence drugs are effective (e. g. valproate, ethosuccimide) but 
drugs specific for convulsive or focal seizures (phenytoin, 
Carbamazepine) are ineffective in suppressing the SWDs [17]. 
Penicillin model of absence seizure 
Penicillin G when given by intramuscular route (≥3 lac unit /kg) to 
cat, epileptiform activity begins after 1 hour which is characterised 
by repeated arrested activity, myoclonus, staring and occasionally 
progressing to GTCS. This model shows spike wave discharge with 
normal background activity in EEG as seen in human absence 
seizure [13]. 
Another method of inducing absence seizure is subcutaneous injection 
of pentylenetetrazole (85 mg/kg). EEG of the treated animals shows 
spike wave discharges. Drugs effective in preventing PTZ induced 
seizure are effective in managing human absence seizure [9]. 
Models of infantile spasm  
Infantile spasms are a type of severe developmental epilepsy which 
begins in the first year of life, commonly between 3 and 10 months 
of age. The neural circuits become epileptogenic after weeks or 
months of an initiating injury. Spasms may respond to 
glucocorticoids, ACTH (adrenocorticotropic hormone) and 
vigabatrin. Unfortunately most anticonvulsants are ineffective in this 
disorder [18-20]. 
Corticotropin-releasing hormone (CRH) model  
Intraperitoneal or intracerebroventricular administration of CRH, 
during the second week of life in rats, causes severe seizures [18, 
21]. Much higher doses of exogenous CRH are required to produce 
seizures at older ages [19]. 
Betamethasone-NMDA model  
Here glucocorticoid (betamethasone administered to pregnant rats 
on gestational day 15) serves as a prenatal stressor which 
predisposes the exposed immature foetal brain to infantile spasms. 
Glucocorticoid sensitizes the foetal brain to postnatal NMDA. The 
same pups are given NMDA on postnatal day15 (P15). They shows 
several changes like tail twisting and flexor spasms, which are 
sensitive to ACTH. This model is said to be a model of cryptogenic 
infantile spasms [17, 21]. 
Tetrodotoxin (TTX) model  
Intrahippocampal infusion of the sodium channel blocker, 
tetrodotoxin (TTX), beginning on Postnatal day 10 to 12 (with the help 
of chronically implanted with osmotic minipumps in the neocortex or 
hippocampus) caused recurrent brief spasm like seizures in rat pups 
[18, 22]. Spasms occur singly or in clusters. The interictal EEG pattern 
is similar to hypsarrhythmia found in infantile spasm [19]. 
Multiple-hit model 
In multiple hit model, severe damage is caused to cortical and 
subcortical structures. On postnatal day 3, lipopolysaccharide is 
injected intracerebrally and doxorubicin is administered into the 
cerebral ventricles. These compounds cause cortical and sub-cortical 
injuries. 
Serotonin decreases brain excitability. To overcome this problem, on 
postnatal day 5, p-chlorophenylalanine (blocker of Tryptophan 
hydroxylase) is injected intra-peritoneally to deplete brain serotonin 
by blocking its synthesis. Treated animals develop recurrent 
seizures from postnatal day 7 to 11, which consisted of spasms in 
clusters. After postnatal day 11 a transition is seen and seizures 
change into limbic seizures. This mimics transition from infantile 
spasms to other seizure types that occurs in human [18, 19]. 
ARX (Aristaless-Related Homeobox) mutation model  
The ARX gene encodes transcription factors that are necessary for 
brain development. In mice models of ARX mutation, variety of 
neurologic defects are seen including mental retardation, epilepsy 
and including infantile spasms [18,19
Down syndrome model- Ts65Dn mouse  
]. 
10% of children with Down syndrome show evidence of infantile 
spasm. Ts65Dn is mouse model of Down syndrome. A normal 1 week 
to 2 months old Ts65Dn mice normally don’t show any clinical 
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evidence of seizure. But when they are exposed to baclofen or γ-
butyrolactone (prodrug of γ-hydroxybutyrate), the animals develop 
clusters of extensor spasms accompanied by similar EEG changes as 
occurs in human infantile spasm. More importantly, ACTH, valproic 
acid, and vigabatrin are succesful in preventing spasms in this model 
[19
Model of myoclonus  
]. 
Post hypoxic myoclonus in rats 
In anaesthetised rat, left femoral artery is cannulated to monitor 
blood pressure and left femoral vein administration of epinephrine 
for resuscitation. Cerebral hypoxia was induced by mechanical 
compression of the aorta and major cardiac vessels by a “L” shaped 
loop such that arterial blood pressure reduces to 0–5 mmHg. After 8 
minutes and 30 seconds, resuscitation should be done with 10 µg/kg 
epinephrine and 4 mEq/kg sodium bicarbonate (intravenous 
injection) and manual thoracic compressions should be given until 
the systemic blood pressure of the animal was returns to normal 
preprocedure level. The animals show spontaneous seizures and 
audiogenic myoclonic jerks [23]. Hypoxia can also be induced by 
cardiac arrest (By intracardiac injection of potassium chloride) [15].  
Models for partial seizures 
Bicuculine 
When bicuculine is topical applied on sensory motor cortex, 
bicuculine treated mice serve as a model of acute simple focal 
epilepsy [13]. 
Bicuculine as a model of chronic simple partial seizure (model 
of systemic focal epileptogenesis) 
Limited volume of rat cerebrum is irradiated to disrupt blood brain 
barrier. 3-6 months later bicuculine methionide (2mg/kg) is to be 
injected systemically. Epileptic focus will be induced which will 
show EEG spikes and features of focal seizure [13]. 
Penicillin model of acute focal seizure 
When Penicillin applied topically to rat cerebral cortex (1.7-3.4 mM 
concentration) with the help of cottonoid pledget, animals start 
showing features suggestive of acute focal seizure. This is a popular 
model to study simple partial seizure [13]. 
Alumina hydroxide 
This is a model of spontaneous recurrent simple focal epilepsy. 4% 
aluminium hydroxide is injected into surgically exposed 
sensorimotor cortex. Recurrent seizures begin after 1-2 months and 
continue for years [12, 24]. 
Zinc sulphate 
This is a model of complex partial seizures with secondary 
generalisation when zinc sulphate is injected Intra-hippocampally 
[10 µl of zinc (ZnSO4.7H2
Colchicine 
O, 200µg/kg)], animals show evidence of 
complex partial seizure which may secondarily generalise [13, 24]. 
Rats and cats develop focal epilepsy when colchicine in agar is 
applied focally to neocortex [13]. 
Kindling 
The behavioural and electrographic components of kindling have 
similarity with human partial onset seizures as it may undergo 
secondary generalisation. Kindling may be electrical or chemical.  
Electrical kindling 
Electrical kindling can be produced by stimulation of specific areas 
of brain (most commonly hippocampus and amygdala). Also corneal 
electroshock kindling also can be done in animal e. g. in mice and 
rats. Mice are kindled by ones daily stimulation of 3mA for 2 seconds 
daily while rats are kindled by stimulating twice daily with 8mA for 
4 seconds (until racine stage 5 seizure is observed). Stimulation of 
the hippocampus and cortex also produces kindled seizures [6, 9]. 
Chemical kindling 
The repeated administration of sub-convulsant doses of PTZ causes 
progressive sensitization to its convulsant effects. Kindling can be 
observed using two different treatment schedules: 1) PTZ 30 mg/kg, 
IP daily or 2) 30 mg/kg, IP every alternate day for eight weeks. With 
these regimes, more than 80% of the animals show convulsions by 
the end of treatment[25]. 
RRHS model 
In rapidly recurring hippocampal sclerosis model, hippocampus of 
rat is stimulated with 10 second trains of titanic electrical stimuli 
(suprathreshold) every few minutes. Parameters observed are 
behavioural seizures, electrographic alterations, threshold of 
afterdischarge and duration of afterdischarge [6]. 
Kainic acid model of temporal lobe epilepsy 
Kainic acid (KA) is an analogue of glutamate. It is a potent agonist 
of glutamate receptors (AMPA/kainate class). Systemic and 
intracerebral administration of KA (4 mg/kg i. v., or 0.8-2.0 µg 
intra-hippocampally) initially induces seizure which last for hours, 
followed by a latent seizure-free period of 3-4 weeks after which 
recurrent spontaneous focal seizures starts appearing. that begin 
between 3 and 4 weeks. KA has special affinity to hippocampus. 
Even when given either systemically or at sites far away from 
hippocampus, KA shows prominent effect on hippocampus. KA 
model can be used as a model of human temporal lobe epilepsy 
(many features are common to both such hippocampal sclerosis 
and mossy fibre sprouting) and epileptogenesis (excitotoxic 
neuronal loss occurs in the dentate gyrus and CA1 and CA3 region 
of hippocampal subfields and subsequent axonal reorganisation as 
occurs in human epilepsy. There is a direct correlation between 
damage of hippocampal subfields and epileptiform activity). 
Similar KA model is reported in mice also. Mice treated with KA 
shows similar epileptic behaviour and histological evidence of 
acute neuronal loss in the CA1 and CA3 regions of hippocampus 
[24, 26]. 
Tetanus toxin 
This is a model of recurrent, chronic partial seizures. A single 
unilateral injection into the hippocampus produces neuronal loss in 
the CA1 pyramidal cell layer of hippocampus [24]. 
Cobalt: Microinjection of cobalt chloride into lateral cerebral 
ventricle produces seizure in rats which is clinically similar to 
kainite induced seizures and amygdale kindling [13]. 
Models of pharmacoresistant seizures 
Despite the use of optimal use of currently available anti-epileptics, 
almost one third of patients continue to suffer from seizure [4, 9]. 
Although maximal electroshock and pentylenetetrazole are fruitful 
models, they are reported to identify drugs acting by same type of 
mechanism of action [5, 27]. 
For better understanding, targeting and discovery of compounds for 
pharmacoresistant epilepsy, the need of the day is an appropriate 
animal model [27]. 
In vivo models 
6-Hz "Psychomotor" Seizure Test  
MES and s. c. Met tests although extremely effective in identifying 
new drugs that may be useful for the treatment of generalized tonic-
clonic and myoclonic seizures, [28] they may miss novel 
antiepileptic drugs that could be useful for the treatment of therapy-
resistant partial seizures. Hence potential antiepileptic drugs are 
also screened for their ability to block seizures in the 6 Hz 
psychomotor seizure test. Here psychomotor seizures are induced 
by a low-frequency (6 Hz) but long-duration (3 sec) stimulus 
delivered through corneal electrodes. Initially 32 mA intensity is 
used and observed for the presence or absence of seizure activity 
but later stimulation current may be increased to 44mA. For 
example, levetiracetam is highly effective in the 6 Hz model but it is 
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ineffective in the MES test. This type of psychomotor seizure is 
characterized by minimal clonic phase which is followed by 
stereotyped, automatistic behaviours (e. g. twitching of vibrissae) 
and Straub-tail. After treatment by an agent, if the animals do not 
display such behaviours, they are considered protected. Seizure 
score can be used as additional measure. These behaviours seems 
similar to the aura of human patients with partial seizures [9]. 
Corneal kindled mouse 
This is a model of human partial epilepsy with secondary 
generalisation. Electric stimulus is applied trans-corneally to the brain 
through optic nerve. After applying 0.5% tetracaine hydrochloride 
solution to each eye, corneal electrodes are applied and a current of 3 
mA, 60 Hz for 3 seconds is applied. This procedure is to be repeated 
twice daily. Stimulations continue till the mouse is fully kindled (5 
consecutive stage 5 seizures). Agents are tested 7 days after last 
stimulation. A seizure score of < 3 is considered protective [9]. 
The behavioural seizure scores are rated as: Stage I - clonus in 
mouth and face, Stage II – stage 1 with associated head nodding, 
Stage III - forelimb clonus, Stage IV - stage 3 with rearing, 
Hippocampal kindled rat model  
Stage V - 
stage 4 with repeated rearing and falling [29]. 
Hippocampal kindled rat is an experimental model of focal seizures 
that become secondarily generalized. This model is useful for 
identifying compounds effective against partial seizures, compounds 
affecting seizure spread and generalization. Adult, Sprague-Dawley 
rats (male) are taken and bipolar electrode is stereotaxically implanted 
(Anaesthesia used is ketamine-xylene) into the ventral hippocampus. 
After that rats are allowed to recover for one week. For kinding 50 Hz, 10 
sec train of 1 ms biphasic 200 µA pulses to be given every 30 min for 6 
hours, for five days on every alternate day. Fully kindled animals start 
showing consistent Racine stage V behavioural seizure. Agents are 
evaluated after one week of stimulus free period 
An effective compound lowers behavioural scores and duration of 
afterdischarge compared to control. Suppressing or delaying 
acquisition of the kindled response indicates that the compound 
under investigation can have antiepileptogenic action [9]. 
[9]. 
Lamotrigine resistant amygdale kindled rats 
In amygdala kindled rats, exposure to low doses of lamotrigine 
during kindling development leads to resistance development to the 
drug in the subsequently kindled animals. Lamotrigine resistant 
kindled rats are refractory to phenytoin and carbamazepine. This 
model is proposed to be a model of drug resistant epilepsy [5]. 
Methylazoxymethanol acetate induced cortical dysplasia 
Pregnant rats are exposed in utero to MAM. These neonates show 
some cortical dysplasia like syndrome in their adulthood. Seizure 
induced in these rats by kainite is refractory to many antiepileptic 
drugs including Carbamazepine and valproate [5]. 
There are lots of other models are there such as Phenytoin resistant 
amygdala kindled rats, [5]. 
In vitro models 
benzodiazepine-resistant convulsive and 
non-convulsive status epilepticus test etc [9]. 
Organotypic hippocampal slice culture model of 
pharmacoresistant epilepsy 
In organotypic hippocampal culture, cell types and most of their 
connections are preserved. If such cultures are exposed to low 
Mg2+
Models for status epilepticus 
or 4-AP, they show robust evidence of status like activity. 
Diazepam fails to control this high epileptiform activity even in very 
high doses. However anaesthaetic concentration of phenobarbitol 
could control these status like events. [7,9,30]. 
Generally status epilepticus can be induced by electrical or chemical 
methods but it can also be induced In vitro in organotypic 
hippocampal slice culture models. 
In vivo 
Repetitive stimulation of hippocampal afferents (e. g. perforant 
path), amygdala and hippocampus are known to produce status 
epilepticus. Again status epilepticus can be induced by chemical 
method also. Many agents like pilocarpine, lithium-pilocarpine, 
diisopropylflurophosphate, kainic acid are widely used to evaluate 
and characterise antiepileptic drugs [3]. 
Kainic acid model 
ICV (intracerebroventricular) injection of 0.4-0.8 µg kainic acid or 
systemic injection of I. P. or s. c. injection of 8-12 mg/kg kainic acid 
induces chemoconvulsion which progresses to develop into status 
epilepticus [3, 31]. 
Pilocarpine model 
Pilocarpine when administered systematically in high doses to rats 
(400mg/kg) or mice (300-350 mg/kg) the animals first develop 
limbic seizures which progress over time to limbic status epilepticus 
[3, 32, 33]. 
Lithium- pilocarpine model 
To enhance the consistency of pilocarpine, small amount of Lithium 
(LiCl 3mEq/kg (i. p.) is given to the animals 24 hours prior to 
administration of pilocarpine (20 mg/kg i. p.). 1mg/kg s. c. [3, 34, 
35]. Scopolamine is to be given 30 minutes prior to pilocarpine 
administration to counteract its peripheral effects. Treated animals 
show behavioural and electrographic evidence of status epilepticus 
for over 5 hours [3]. 
There are numerous other chemical models of SE like Flurothyl 
model, Cobalt-Homocysteine model etc [3]. 
In-vitro 
Low or zero Mg2+
The zero Mg
model in entorrhinal- hippocampal slices 
2+model in entorrhinal-hippocampal slices is of 
particular importance. [36-39]. Zero level of Mg2+
4-aminopyridine is a popular in-vitro method because of it is a 
potent epileptic agent and the actions are highly reproducible in 
slices. Again another variety called organotypic hippocampal slices 
are also commonly used to study status epilepticus and to evaluate 
drugs effective against it [3]. 
 produces 
synchronised epileptiform discharges in hippocampal slices, the first 
stage is epileptiform discharges that are sensitive to benzodiazepine 
but in the second stage (occurs after around one hour), late 
recurrent discharges occurs which are insensitive to 
benzodiazepines [36, 38]. 
Genetic models of epilepsy 
There are many seizure prone animals; epilepsy in these animals 
closely mimics human epilepsy. Some important and validated 
models are discussed below. 
Spontaneous epileptic rats 
when tremor homozygous rats are allowed to mate with zitter 
homozygous rat, the new progenies become spontaneously epileptic. 
They show behavioural responses like wild jumping and tonic 
convulsions in absence of any external stimuli [6, 15]. 
Audiogenic seizure prone mice (DBA/2J) 
On exposure to high frequency high intensity sound (10-20 kHz, 90-
120 dB) they show behavioural alterations like wild running and 
generalised tonic clonic seizure [6, 15]. 
Genetically epilepsy prone rats (GEPR rats) 
It is one of the best known genetic epilepsy model. Both GPER 3 and 
GPER 9 has moderate to severe degree of seizure predisposition. 
GPER 3 responds to a sound stimulus by generalised clonus and 
GPER 9 presents with tonic extensor convulsion. In GPER, input from 
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forebrain circuit activates brainsten seizure circuit which results in 
complex partial seizures with secondary generalisation [6, 40]. 
Tottering mouse (tg/tg strain) 
Shows 6-7 per second spike wave discharges. Anti absence drugs are 
effective in this model [6, 15]. 
Quacking mouse 
This type of mouse when handled by tail and slowly rotated, exhibits 
generalised tonic clonic seizures [15]. 
EL mouse 
It is a model of hereditary focal epilepsy precipitated by sensory 
stimulation (vestibular stimuli such as spinning or tossing, animals 
show feature of complex partial seizure) [15, 24], Other important 
genetic models of epilepsy are Photosensitive fowl, [6,15]. 
Mongolian gerbils (Meriones Unguiculatus), [6]. Photosensitive 
baboons (Papio Papio), [6, 15]. Epileptic dogs, Mocha, Stargazer and 
Lurcher [6, 15]. 
Alternative to animal models in epilepsy 
The zebra fish model (Danio Rerio):  
Wild type larval zebrafish is to be taken. PTZ is dissolved in the 
bathing medium at a concentration between 2.5 to 15 mM at pH 7. 
Freely swimming zebra fish are exposed to PTZ in a petridish or 96 
well felcon plates. Electrophysiologic studies can be done by 
embedding the fish on agar plate.  
Its behaviour after exposure to PTZ is graded as stage-1, increase in 
swim activity, stage 2, rapid circling along the outer edge of the well, 
stage 3, brief head to tail convulsions followed by free floating (loss 
of posture) [41, 42]. 
Other important models of epilepsy are Caenorhabditis elegans 
(worms) and Drosophila melanogaster (Fruit flies) [41]. 
The in vitro mechanism of action test  
In an effort to gain insight into the potential mechanism of action of 
the anticonvulsant compound under investigation, its interactions 
with voltage- and receptor-gated ion channels are examined using 
whole-cell patch-clamp electrophysiology techniques in cell cultures. 
In whole-cell patch clamp recording technique, cortical cells from 
15-gestational-day-old Swiss Webster mouse fetuses are cultured 
and are used 2-3 weeks after plating. Whole-cell recordings from a 
murine neuroblastoma (N1E 115) cell line are used to characterize the 
effects of the test compound on voltage-gated sodium channels [9]. 
Other effects observed are voltage-activated Na currents in cultured 
neocortical neurons, effect of the drug on GABA-induced Cl– fluxes 
across the membrane in mouse cortical neurons and cerebellar 
granule cells, effect of the drug on kainite and NMDA evoke inward 
current on cultured hippocampal neurons etc. Receptor binding and 
neurotransmitter uptake studies can be performed on GABA, NMDA 
and monoamine receptors, or on GABA, adenosine, dopamine, 
serotonin, norepinephrine and glutamate transport systems [43]. 
Models targeting epileptogenesis 
Current used models e. g. the MES model and the PTZ model are 
models of seizures (ictogenesis), but they are not models of 
epileptogenesis [27]. Hence, there is a need for properly validated 
models of epileptogenesis which can be used for screening of newer 
chemical entities [4].  
No current antiepileptic drug can prevent or modify epilepsy occurring 
after brain insults (post-traumatic epilepsy) [44]. The proposed 
models are post status epileptius- temporal lobe epilepsy (Post SE-
TLE), Models of kindling and traumatic brain injury (TBI) [4].  
In Post SE-TLE model, first SE is induced by electrical or chemical 
stimulation (Pilocarpine or Kainate). After 1-4 weeks post SE, the 
animals starts showing spontaneous or recurrent seizures with or 
without hippocampal damage. The time from initial insult to 
development of epilepsy is the period of epileptogenesis. Enormous 
effort is going on to develop new antiepileptic drugs [4]. 
Computational models 
The computational models can be classified as Deterministic micro-
scale model, Detreministic macro scale model, Non-deterministic 
stochastic models, and Non deterministic statistical models. Micro 
scale models are concerned with dynamical behaviour of neurons, 
neuronal morphology and ion channels. Neural networks are 
constructed using Hodgkin Huxley framework. Macro-scale models 
try to explore dynamics of neuronal population rather than 
concentrating on individual neurons.  
They try to explore dynamics resulting from interaction of many 
brain areas or regions. Non deterministic models focus on inherent 
variability lying in the recorded brain activity. There are lots of non 
deterministic statistical models are there like autoregressive model, 
generalised linear models, structural equation models.  
To enhance efficacy of these tools, these are supported by advanced 
techniques like support vector machines and artificial neural 
networks. Hidden marcov model and marcov chain model has 
significant application in epilepsy research [45]. 
Other important computational models used in epilepsy research 
are realistic models of the corticothalamic loop, Compartmental 
models of hippocampus, time independent models of seizure 
intervals, time dependent models of seizure intervals etc [46]. 
Databases of published models can be searched at ModelDB. Some 
related databases are CoCoDat, The Database of Cortical 
Microcircuitry”. To run simulations some tools are there like 
MATLAB, Mathematica, PyDSTool etc. Softwares used solely for 
neuronal modelling are NEURON, Brian, Nest, Parallel neural Circuit 
Simulator and Genesis [46]. 
CONCLUSION 
In summary, the above discussed models can be used to identify 
and characterise new chemical entities for treatment of epilepsy. 
Primary screening by NIH primarily concentrates on MES and Sc. 
PTZ test. Characterisation of anticonvulsant compound is not the 
final job. These compounds are also to be tested for 
neurotoxicity (Rota rod test, gait and stance test), Proconvulsant 
evaluation (intravenous PTZ threshold test) and tolerance and 
metabolism studies along with safety issues before entering into 
next phase [9]. 
Animal models are playing the main role in anticonvulsant screening 
and it is unlikely that they may be replaced by in-vitro methods 
although they can supplement them [4]. Pharmaceutical industry 
primarily uses mechanism specific approach as primary screening 
tool and mechanism independent models are used to verify different 
mechanism based hypothesis. Seizure type models are used for 
secondary evaluation [6]. 
Different models of epilepsy significantly improved our 
understandings about epieptogenesis and ictogenesis [5]. We need 
new and more validated animal models which can mimic different 
types of human epilepsy more closely and improve our 
understandings about epilepsy far better.  
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